Stock acquisition rights linked to the operating profit target under the medium-term management plan
First written in FY2017-Q3. 7 of 15 entries say "Advanced", first in FY2018. Latest entry: 2026-07-09.
The whole theme swung hardest in 2020: 2 of 17 companies on the "Worse" side.
13 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「Series 16 Stock Acquisition Rights Date of resolution 22 May 2025 Number of stock acquisition rights* 20,900 (Note 1) Class, details and number of shares underlying the stock acquisition rights* Common stock: 2,090,000 shares (Note 1) Exercise period for the stock acquisition rights* 15 May 2029 to 15 June 2030」
The issuance details and exercise period of the Series 16 Stock Acquisition Rights, which have tiered EBITDA conditions ranging from ¥9.85 billion to ¥13.5 billion for the fiscal year ending March 2029, were specifically disclosed. The issue comprises 20,900 rights and 2,090,000 underlying shares. - FY2025RaisedAnnual report
「If, during the fiscal year ending March 2029, EBITDA exceeds each of the amounts listed below, each holder of stock acquisition rights may exercise the rights allocated to that holder up to the percentage specified for each item below (the “permitted exercise percentage”). (a) If EBITDA reaches ¥9.85 billion or more: permitted exercise percentage: 20% (b) If EBITDA reaches ¥10.5 billion or more: permitted exercise percentage: 50% (c) If EBITDA reaches ¥11.5 billion or more: permitted exercise percentage: 67% (d) If EBITDA reaches ¥12.5 billion or more: permitted exercise percentage: 83% (e) If EBITDA reaches ¥13.5 billion or more: permitted exercise percentage: 100%」
For the Series 16 Stock Acquisition Rights, the measurement year was extended from the fiscal year ending March 2028 to the fiscal year ending March 2029, and the initial EBITDA condition was raised from ¥9.5 billion to ¥9.85 billion. The final condition remains ¥13.5 billion. - FY2024RaisedAnnual report
「① If, during the fiscal year ending March 2028, EBITDA exceeds each of the amounts listed below, each holder of stock acquisition rights may exercise the rights allocated to that holder up to the percentage specified for each item below (the “permitted exercise percentage”). (a) If EBITDA reaches ¥9.5 billion or more: permitted exercise percentage: 20% (b) If EBITDA reaches ¥10.5 billion or more: permitted exercise percentage: 50% (c) If EBITDA reaches ¥11.5 billion or more: permitted exercise percentage: 67% (d) If EBITDA reaches ¥12.5 billion or more: permitted exercise percentage: 83% (e) If EBITDA reaches ¥13.5 billion or more: permitted exercise percentage: 100%」
For the Series 14 Stock Acquisition Rights, the fiscal year ending March 2028 was set as the measurement year, with tiered EBITDA-based exercise conditions ranging from ¥9.5 billion to ¥13.5 billion. The exercise period and target levels were raised from the previous fiscal year ending March 2027 structure, whose maximum target was ¥13.0 billion. - FY2024-Q3RaisedAnnual report
「① If, during the fiscal year ending March 2027, EBITDA exceeds each of the amounts listed below, each holder of stock acquisition rights may exercise the rights allocated to that holder up to the percentage specified for each item below (the “permitted exercise percentage”). (a) If EBITDA reaches ¥9.0 billion or more: permitted exercise percentage: 20% (b) If EBITDA reaches ¥10.0 billion or more: permitted exercise percentage: 50% (c) If EBITDA reaches ¥11.0 billion or more: permitted exercise percentage: 67% (d) If EBITDA reaches ¥12.0 billion or more: permitted exercise percentage: 83% (e) If EBITDA reaches ¥13.0 billion or more: permitted exercise percentage: 100%」
For the Series 13 Stock Acquisition Rights, a five-tier exercise structure was added, with EBITDA conditions ranging from ¥9.0 billion to ¥13.0 billion for the fiscal year ending March 2027. The exercise period and final target were extended from the previous structure for the fiscal year ending March 2026, whose maximum target was ¥12.5 billion. - FY2023-Q3AdvancedAnnual report
「Series 12 Stock Acquisition Rights Number of stock acquisition rights* 2,300 (Note 1) Class, details and number of shares underlying the stock acquisition rights* Common stock: 230,000 shares (Note 1) Exercise period for the stock acquisition rights* 15 May 2026 to 15 June 2026」
The Series 12 Stock Acquisition Rights were issued with five EBITDA-based conditions ranging from ¥5.5 billion to ¥12.5 billion for the fiscal year ending March 2026, and the structure covering 230,000 shares was specified. - FY2023-Q2RaisedAnnual report
「If, during the fiscal year ending March 2026, EBITDA exceeds each of the amounts listed below, each holder of stock acquisition rights may exercise the rights allocated to that holder up to the percentage specified for each item below (the “permitted exercise percentage”). (a) If EBITDA reaches ¥5.5 billion or more: permitted exercise percentage: 20% (b) If EBITDA reaches ¥7.0 billion or more: permitted exercise percentage: 50% (c) If EBITDA reaches ¥8.5 billion or more: permitted exercise percentage: 67% (d) If EBITDA reaches ¥10.5 billion or more: permitted exercise percentage: 83% (e) If EBITDA reaches ¥12.5 billion or more: permitted exercise percentage: 100%」
For the Series 11 Stock Acquisition Rights, five EBITDA-based exercise conditions were established for the fiscal year ending March 2026, ranging from ¥5.5 billion to ¥12.5 billion. The exercise period and each target level were raised from the previous structure for the fiscal year ending March 2025, whose maximum target was ¥12.0 billion. - FY2022Change in the number of underlying sharesAnnual report
「Number of stock acquisition rights* 6,600 [5,600] (Note 1) Class, details and number of shares underlying the stock acquisition rights* Common stock: 660,000 shares [560,000 shares] (Note 1)」
For the Series 10 Stock Acquisition Rights, the number of underlying shares as of the end of the month preceding the filing date was changed from 660,000 shares to 560,000 shares. - FY2022-Q2RaisedAnnual report
「① If, during the fiscal year ending March 2025, EBITDA exceeds each of the amounts listed below, each holder of stock acquisition rights may exercise the rights allocated to that holder up to the percentage specified for each item below (the “permitted exercise percentage”). (a) If EBITDA reaches ¥5.0 billion or more: permitted exercise percentage: 20% (b) If EBITDA reaches ¥6.5 billion or more: permitted exercise percentage: 50% (c) If EBITDA reaches ¥8.0 billion or more: permitted exercise percentage: 67% (d) If EBITDA reaches ¥10.0 billion or more: permitted exercise percentage: 83% (e) If EBITDA reaches ¥12.0 billion or more: permitted exercise percentage: 100%」
For the Series 10 Stock Acquisition Rights, a five-tier exercise structure was added, with EBITDA conditions ranging from ¥5.0 billion to ¥12.0 billion for the fiscal year ending March 2025 and full exercise permitted at the final tier. The exercise period and final target were extended from the previous structure, which applied to the fiscal year ending March 2024 and had a maximum target of ¥10.0 billion. - FY2020AdvancedAnnual report
「① If, during the fiscal year ending March 2024, operating profit exceeds each of the amounts listed below, each holder of stock acquisition rights may exercise the rights allocated to that holder up to the percentage specified for each item below (the “permitted exercise percentage”). (a) If operating profit reaches ¥3.8 billion or more: permitted exercise percentage: 10% (b) If operating profit reaches ¥5.0 billion or more: permitted exercise percentage: 50% (c) If operating profit reaches ¥6.5 billion or more: permitted exercise percentage: 67% (d) If operating profit reaches ¥8.2 billion or more: permitted exercise percentage: 83% (e) If operating profit reaches ¥10.0 billion or more: permitted exercise percentage: 100%」
For the Series 9 Stock Acquisition Rights, a five-tier exercise structure based on operating profit for the fiscal year ending March 2024 was disclosed, along with specific issuance details for 1,550,000 underlying shares. - FY2020-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period are as follows. Series 8 Stock Acquisition Rights Number of stock acquisition rights* 5,900 (Note 1) Number of shares underlying the stock acquisition rights* 590,000 shares (Note 1)」
The issuance details of the Series 8 Stock Acquisition Rights, comprising 5,900 rights and 590,000 underlying shares, were specifically disclosed during the quarter. The exercise conditions are based on operating profit of ¥6.5 billion, ¥8.2 billion and ¥10.0 billion for the fiscal year ending March 2024. - FY2019RaisedAnnual report
「① If, for the fiscal year ending March 2024, operating profit in the consolidated statement of income reported in the Company’s summary of financial results exceeds each of the amounts below, holders of the stock acquisition rights may exercise them up to the percentage specified for each item below, referred to as the “exerciseable percentage.” (a) If operating profit is ¥6,500 million or more, exerciseable percentage: 50% (b) If operating profit is ¥8,200 million or more, exerciseable percentage: 75% (c) If operating profit is ¥10,000 million or more, exerciseable percentage: 100%」
The new Series 8 stock acquisition rights specify operating profit of ¥6,500 million, ¥8,200 million, and ¥10,000 million for the fiscal year ending March 2024 as successive exercise conditions, allowing 100% exercise at the final stage, representing a performance-linked design with higher targets and a longer time horizon than before. - FY2018AdvancedAnnual report
「For the consolidated fiscal year, revenue was ¥10,266,541 thousand, up 36.3% year on year. This was mainly due to the full-year contribution of 株式会社三光アド, which joined the Group in the previous consolidated fiscal year, significant growth in the performance of existing businesses, efforts to expand customer acquisition through site renewals and original sales promotion initiatives, and the strengthening and enhancement of the organizational structure.」
Operating profit for the fiscal year ended March 2018 was ¥3,322,220 thousand, exceeding the exercise condition for that fiscal year of ¥2,600 million or more. Progress was made regarding the exerciseable percentage of the performance-linked stock acquisition rights. - FY2017-Q3First statedAnnual report
「Holders of the stock acquisition rights may exercise the stock acquisition rights allocated to them, up to the percentages specified below, if the operating profit reported in the summary of financial results for each fiscal year of the Company from the fiscal year ended March 2017 through the fiscal year ending March 2021 meets the following conditions. (a) If operating profit for the fiscal year ended March 2017 is ¥2,050 million or more, 7% of the total number of stock acquisition rights allocated to each holder may be exercised from the first day of the month following the month in which the Company submits its summary of financial results for the fiscal year in which the condition was met. (b) If operating profit for the fiscal year ended March 2018 is ¥2,600 million or more, 14% of the total number of stock acquisition rights allocated to each holder may be exercised from the first day of the month following the month in which the Company submits its summary of financial results for the fiscal year in which the condition was met. (c) If operating profit for the fiscal year ended March 2019 is ¥3,200 million or more, 21% of the total number of stock acquisition rights allocated to each holder may be exercised from the first day of the month following the month in which the Company submits its summary of financial results for the fiscal year in which the condition was met. (d) If operating profit for the fiscal year ended March 2020 is ¥4,000 million or more, 28% of the total number of stock acquisition rights allocated to each holder may be exercised from the first day of the month following the month in which the Company submits its summary of financial results for the fiscal year in which the condition was met. (e) If operating profit for the fiscal year ending March 2021 is ¥5,000 million or more, 30% of the total number of stock acquisition rights allocated to each holder may be exercised from the first day of the month following the month in which the Company submits its summary of financial results for the fiscal year in which the condition was met.」
Stock acquisition rights were issued with operating profit targets for the fiscal years ended March 2017 through March 2021 as exercise conditions, and exerciseable percentages set according to the achievement of successive targets ranging from ¥2,050 million to ¥5,000 million.